Regressions produced in breast cancer lesions by a lymphokine fraction from a human lymphoid cell line.
D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002460:Cell Line; D002478:Cells, Cultured; D003470:Culture Media; D003956:Dialysis; D004890:Erythema / Q000139:chemically induced; D005260:Female; D005374:Filtration; D005612:Freeze Drying; D006168:Guinea Pigs; D006801:Humans; D008214:Lymphocytes / Q000032:analysis*; D008222:Lymphokines / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008970:Molecular Weight; D009182:Mycosis Fungoides / Q000188:drug therapy; D009362:Neoplasm Metastasis
D003470:Culture Media; D008222:Lymphokines